LOS ANGELES, CA--(Marketwired - June 27, 2017) - ViaDerma, Inc. (OTC PINK: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, recently announced today that the Company has received its National Drug Code (NDC) 69006-010-00 from the Food and Drug Administration (FDA) for its new over the counter or OTC medication, Prolayed, a male...
With today's news, the fact that the case has the potential to be dismissed, and FDA approval on the horizon, I think today marks the start of a long bull trend for the rest of the summer. VDRM continues to honor their word, and continues to show how much they care about investors. Happy to apart of this company and excited for the future. Millionaires will be made!
I think we are ready to reach 0.06-0.10 within the coming 3 months. Going to be a HOT summer. Chart looks very strong and poised for success.
Provisional patent numbers have arrived!! This is absolutely HUGE. Lets also not forget we've got a conference coming Friday which will be bring many new ideas to the company. Millionaires will be made!!!
Can't get enough VDRM at these prices! Anyone who has been following my posts knows I'm very long on this stock and coming back down to these prices is a pure gift. With the CEO speaking at a large conference at the end of the month, lots of eyes will be on this company. $$'s by December or sooner IMO. Millionaires will be made!